PHIO CIK: 1533040

Phio Pharmaceuticals Corp.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
–
FY22:
–
FY23:
0
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−13.5
FY22:
−11.5
FY23:
−10.8
FY24:
−7.39
FY25:
−9.22
(positive)
Change from FY21 to FY25
millions USD
FY21:
−13.3
FY22:
−11.3
FY23:
–
FY24:
−7.35
FY25:
−9.22
(positive)
Change from FY21 to FY25
millions USD
FY21:
−13.3
FY22:
−11.5
FY23:
–
FY24:
−7.15
FY25:
−8.70
(positive)
Change from FY21 to FY25
millions USD
FY21:
−13.3
FY22:
−11.5
FY23:
−10.8
FY24:
−7.15
FY25:
−8.70

All amounts in millions USD Data sources:SEC EDGARTwelve Data